A Study Evaluating INIPARIB in Combination With Chemotherapy to Treat Triple Negative Breast Cancer Brain Metastasis

Clinical trial NCT01173497 · COMPLETED

Trial details

NCT number: NCT01173497
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Estrogen Receptor Negative (ER-Negative) Breast Cancer Progesterone Receptor Negative (PR-Negative) Breast Cancer Human Epidermal Growth Factor Receptor 2 Negative (HER2-Negative) Breast Cancer Brain Metastases

Start date: 2010-07-01
Primary completion: 2012-10-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.